Ionis to present at upcoming investor conferences
- Guggenheim Virtual Genomic Medicines and Rare Disease Days on
Tuesday, April 4, 2023
- 22nd Annual
Needham Virtual Healthcare Conferenceon Monday, April 17, 2023
A live webcast of the presentations can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. The replay will be available on the Ionis website within 48 hours and will be archived for a limited time.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis, visit www.ionispharma.com and follow us on Twitter @ionispharma.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301782684.html
Ionis Investor Contact: D. Wade Walke, Ph.D., email@example.com, 760-603-2331 Ionis Media Contact: David Polk, firstname.lastname@example.org, 760-603-4679